Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Alpelisib × 30 days × Clear all

Status

Sponsor Class

Study Type

Interventional 4 Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1

Interventions

Blood Specimen Collection 18 Surveys and Questionnaires 17 Specimen Handling 11 Radiotherapy 9 Watchful Waiting 7 Immune Checkpoint Inhibitors 7 Observation 6 Interviews as Topic 6 Biopsy 6 ribociclib 4 Tissue Banks 4 lenvatinib 3 enzalutamide 3 darolutamide 3 Standard of Care 3 Magnetic Resonance Spectroscopy 3 Liquid Biopsy 3 Letrozole 3 Drug Therapy 3 Anastrozole 3 trametinib 2 regorafenib 2 pertuzumab 2 pembrolizumab 2 efgartigimod alfa 2 dabrafenib 2 apalutamide 2 Tomography, X-Ray Computed 2 Surgical Procedures, Operative 2 Sorafenib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05022342 2026-02-23

SPEAR

Novartis

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡